Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models"

Science

Volumn 340, Issue 6135, 2013, Pages 924-

  Veeraraghavalu, Karthikeyan ^a   Zhang, Can ^b   Miller, Sean ^b   Hefendehl, Jasmin K ^c   Rajapaksha, Tharinda W ^d   Ulrich, Jason ^e   Jucker, Mathias ^c   Holtzman, David M ^e   Tanzi, Rudolph E ^b   Vassar, Robert ^d   Sisodia, Sangram S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d NORTHWESTERN UNIVERSITY   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; APOLIPOPROTEIN E; BEXAROTENE; TETRALIN DERIVATIVE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; INTERSTITIAL FLUID; MICROGLIA; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BRAIN; MALE; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; APOLIPOPROTEINS E; BRAIN; MALE; TETRAHYDRONAPHTHALENES;

MLCS; MLOWN;

EID: 84877946097     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1235505     Document Type: Note

References (9)

1. D. L. Price, S. S. Sisodia, Annu. Rev. Neurosci. 21, 479 (1998).
2. P. E. Cramer et al ., Science 335, 1503 (2012).
3. J. L. Jankowsky et al ., Biomol. Eng. 17, 157 (2001).
4. R. Radde et al., EMBO Rep. 7, 940 (2006).
5. J. Wang, H. Tanila, J. Puoliväli, I. Kadish, T. van Groen, Neurobiol. Dis. 14, 318 (2003).
6. S. H. Kim et al ., J. Biol. Chem. 276, 43343 (2001).
7. S. B. Morris, R. P. DeShon, Psychol. Methods 7, 105 (2002).
8. H. Oakley et al., J. Neurosci. 26, 10129 (2006).
9. Y. S. Eisele et al., Science 330, 980 (2010).